Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides

Conditions:   Mycosis Fungoides;   Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;   Sezary Syndrome Interventions:   Procedure: Extracorporeal Photopheresis;   Biological: Mogamulizumab;   Other: Quality-of-Life Assessment Sponsor:   Emory University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials